Sunesis Pharmaceuticals Inc. (SNSS) Drops 5.45% on January 06

Equities Staff |

Sunesis Pharmaceuticals Inc. (SNSS) was one of the Russell 2000's biggest losers for Wednesday January 06 as the stock slid 5.45% to $0.87, a loss of $-0.0501 per share. Starting at an opening price of $0.92 a share, the stock traded between $0.85 and $0.92 over the course of the trading day. Volume was 190,514 shares over 473 trades, against an average daily volume of 488,859 shares and a total float of 75.47 million.

The losses send Sunesis Pharmaceuticals Inc. down to a market cap of $65.65 million. In the last year, Sunesis Pharmaceuticals Inc. has traded between $3.72 and $0.74, and its 50-day SMA is currently $0.88 and 200-day SMA is $1.73.

Sunesis Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers.

Sunesis Pharmaceuticals Inc. is based out of South San Francisco, CA and has some 39 employees. Its CEO is Daniel N. Swisher.

For a complete fundamental analysis analysis of Sunesis Pharmaceuticals Inc., check out Equities.com’s Stock Valuation Analysis report for SNSS. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

AfterMaster Inc

Studio One Media Inc is a diversified media and technology company. It is engaged in the development and commercialization of proprietary, edge audio and video technologies for professional and consumer…

Private Markets

8tracks

Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.

GoCoin

Blockchain currencies (e.g. Bitcoin) provide a new disruptive way to transfer value between parties over the internet as opposed to going through banks. GoCoin provides online merchants with a suite…